Use of OCPs are known to protect against following malignancies except:
**Core Concept**
The use of Oral Contraceptive Pills (OCPs) is associated with a reduced risk of certain malignancies due to their effects on hormone-sensitive tissues and the regulation of cell growth. OCPs contain estrogen and progestin, which modulate the growth and differentiation of cells, thus exerting a protective effect against specific cancers.
**Why the Correct Answer is Right**
OCPs are known to protect against endometrial, ovarian, and colorectal cancers. The protective effect against endometrial cancer is attributed to the anti-estrogenic effects of progestin, which counteracts the proliferative effects of estrogen on the endometrium. The decreased risk of ovarian cancer is thought to be due to the suppression of ovarian follicular growth and the decrease in estrogen production. The protective effect against colorectal cancer may be related to the increased expression of beta-catenin, which inhibits the growth of colorectal cancer cells.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because OCPs do not provide significant protection against breast cancer. In fact, the use of OCPs may slightly increase the risk of breast cancer, particularly with long-term use.
**Option B:** This option is incorrect because OCPs do not provide significant protection against ovarian cancer of germ cell origin. The protective effect of OCPs is primarily seen in epithelial ovarian cancers.
**Option C:** This option is incorrect because OCPs do not provide significant protection against cervical cancer. The protective effect of OCPs is primarily seen in cancers that are sensitive to estrogen and progestin.
**Clinical Pearl / High-Yield Fact**
It is essential to note that the protective effect of OCPs against certain malignancies is time-dependent and may be lost after cessation of use.
**Correct Answer: A. Breast cancer.**